These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29435012)

  • 21. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
    Li Y; Zu L; Wu H; Zhang F; Fan Y; Pan H; Du X; Guo F; Zhou Q
    Thorac Cancer; 2022 Feb; 13(3):430-441. PubMed ID: 34953057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression.
    He Z; Liu Y; Xiao B; Qian X
    Biochem Biophys Res Commun; 2015 Feb; 457(3):235-41. PubMed ID: 25576360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.
    Peng Y; Liu YM; Li LC; Wang LL; Wu XL
    PLoS One; 2014; 9(4):e94422. PubMed ID: 24736504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
    Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
    Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
    Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
    Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.
    Vescarelli E; Gerini G; Megiorni F; Anastasiadou E; Pontecorvi P; Solito L; De Vitis C; Camero S; Marchetti C; Mancini R; Benedetti Panici P; Dominici C; Romano F; Angeloni A; Marchese C; Ceccarelli S
    J Exp Clin Cancer Res; 2020 Jan; 39(1):3. PubMed ID: 31898520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-198 inhibition of HGF/c-MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non-small-cell lung cancer.
    Zhu L; Xue F; Xu X; Xu J; Hu S; Liu S; Cui Y; Gao C
    J Cell Biochem; 2018 Sep; 119(9):7873-7886. PubMed ID: 29943841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of EG00229 on Radiation Resistance of Lung Adenocarcinoma Cells.
    Cong L; Yi J; Qiu S; Wang R; Jin S; Jiang R; Cong X
    J Cancer; 2021; 12(20):6105-6117. PubMed ID: 34539883
    [No Abstract]   [Full Text] [Related]  

  • 36. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
    Wang L; Liu LF; Zhou L; Liao F; Wang J
    J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00210 plays oncogenic roles in non-small cell lung cancer by sponging microRNA-328-5p.
    Liu Z; Xu L; Zhang K; Guo B; Cui Z; Gao N
    Exp Ther Med; 2020 May; 19(5):3325-3331. PubMed ID: 32266029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.
    Li L; Liu H; Du L; Xi P; Wang Q; Li Y; Liu D
    Oncol Res; 2018 May; 26(4):547-556. PubMed ID: 28800787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.